💨 Abstract

Indian pharmaceutical company Torrent Pharmaceuticals reported a smaller-than-expected Q3 profit due to the closure of its insulin manufacturing facility and currency depreciation in Brazil. Revenue grew 3%, but missed analyst estimates. The company's profit and revenue lagged behind competitors, as rival Granules India and Mankind Pharma also saw lower profits and revenue.

Courtesy: theprint.in